http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180112315-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff283c7d6797987f01db547f606e6b32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b227bb4a6bb2e4a298835c360545fe9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-73 |
| filingDate | 2017-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_525b2f9c37823d036eb545625348f750 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8284d4c699950f9593816f2c64696a64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_205ee0b2418ac4695fbf3286ff5b8643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ab90e842e820fc64f20144ff264d13b |
| publicationDate | 2018-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180112315-A |
| titleOfInvention | rubus coreanus and sanguiin H-6 having estrogenic activity and anti-cancer activity against breast cancer and menopausal or hormonal disorder |
| abstract | The present invention relates to a bacterium extract having an estrogen activity and a breast cancer inhibiting effect, sanguinin H-6 and a method for producing the same. The present invention provides a bacterium extract used for estrogenic activity and breast cancer inhibiting activity. The present invention also provides sanguinin H-6, which is used for estrogenic activity and breast cancer inhibitory activity of a woman extracted from bokbunja extract. Also, the present invention provides a bacterium extract used for estrogenic activity and breast cancer inhibiting activity, characterized by using 1 to 300 μg per 1 ml of human breast cancer. Also, the present invention provides sanguinin H-6, which is used for estrogenic activity and breast cancer inhibitory effect of women, which is characterized by application of 1 to 300 μg per 1 ml of human breast cancer. The present invention also provides a process for extracting brambled methanol extract from brambled fruit with methanol (step 1) The resulting brambled methanol extract was suspended in distilled water and then put in a seperatory funnel and fractionated in the order of CH 2 Cl 2 (dichloromethane), EtOAc (ethyl acetate) and n-BuOH (n-butyl alcohol) (Step 2), Separation of the fractions from each of the above fractions in EtOAc (ethyl acetate) into fractions by a chromatographic method using a Sephadex LH-20 column (step 3) The above-described fractions are purified by HPLC and recrystallized with MeOH (step 4), which provides a method for producing Sanguinin H-6. |
| priorityDate | 2017-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.